Myo-inositol + folic acid

DIETARY_SUPPLEMENT4 trials

Sponsors

AGUNCO Obstetrics and Gynecology Centre, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

Conditions

OligoasthenospermiaPCOSPolycystic Ovary SyndromeSperm Quality

Phase 4

Myo-inositol Versus D-chiro-inositol in the Treatment of Polycystic Ovary Syndrome and Insulin Resistance: Evaluation of Clinical, Metabolic, Endocrine and Ultrasound Parameters

CompletedNCT01514942

AGUNCO Obstetrics and Gynecology CentrePCOS

Updated: 2012-01-23

Role of Melatonin Supplementation in Follicular Fluid of in Vitro Fertilization (IVF) Patients With Polycystic Ovarian Syndrome

CompletedNCT01540747

AGUNCO Obstetrics and Gynecology CentrePolycystic Ovary Syndrome

Updated: 2012-02-29

Effect of Treatment With Myo-inositol on Human Semen Parameters in Patients Undergoing In Vitro Fertilization Cycles

CompletedNCT01560065

AGUNCO Obstetrics and Gynecology CentreOligoasthenospermia, Sperm Quality

Updated: 2012-03-22

Unknown Phase

Involvement of Reticulum Endoplasmic Stress in the Physiopathology of Polycystic Ovary Syndrome

CompletedNCT02302326

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat ValencianaPolycystic Ovary Syndrome

Start: 2013-01-31End: 2019-12-31Target: 50Updated: 2020-02-26

Related Papers

A pilot double-blind randomised placebo-controlled dose–response trial assessing the effects of melatonin on infertility treatment (MIART): study protocol

BMJ Open2014-08-0129 citations